Tag: Mithra
Mithra exercises a put option under the capital commitment agreement with LDA Capital – 11/17/2022 at 17:45
Liège, Belgium, 17 November 2022 – 17:45 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, today announces that it has exercised a put option, as part…
Mithra announces access to the second tranche of the loan facility concluded with Highbridge/Whitebox – 31/10/2022 at 07:30
Liège, Belgium, October 31, 2022 – 7:30 CET – Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the “Company” or “Mithra”), a company dedicated to women’s health, today announces that it has…
Mithra and Fuji announce approval of NEXTSTELLIS™ in Thailand – 2022-10-24 07:30
October 24, 2022 – 7:30 CET – Tokyo, Japan and Liège, Belgium – Fuji Pharma Co., Ltd. (Tokyo Stock Exchange: 4554, “Fuji”) and Mithra Pharmaceuticals, SA (Euronext Brussels: MITRA, “Mithra”)…
Mithra: not yet the ‘breakeven'”
By Claude Leguilloux Published on 09/23/2022 at 09:37 Mithra’s revenue was impacted by weaker-than-expected Estelle sales in 2021 in the USA. Excess inventory limited…
Mithra secures up to EUR 100 million funding from existing investors and redeems EUR 34.1 million of its convertible bonds due 2025 at a discount to par – 08/08/2022 at 08:30
Liège, Belgium, August 8, 2022 – 8:30 CET – Mithra (Euronext Brussels: MITRA) (the “Company” or “Mithra”), a company dedicated to women’s health, today announces that it has entered into…
Mayne Pharma and Mithra Announce FDA Approval of HLOETTE®, a Generic Version of NUVARING® – 08/08/2022 at 07:30
August 08, 2022, 07:30 CEST – Adelaide, Australia and Liège, Belgium – Mayne Pharma Group Limited (ASX: MYX) and Mithra Pharmaceuticals, SA (Euronext Brussels: MITRA) are pleased to announce that…
Mithra announces the launch by Mayne Pharma of the new NEXTSTELLIS® consumer campaign in the United States – 08/01/2022 at 07:30
Liège, Belgium, August 01, 2022 – 7:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, today announces that its US business partner, Mayne Pharma Group Limited…
Mithra announces changes to its board of directors – 07/06/2022 at 17:45
Liège, Belgium, July 06, 2022 – 5:45 PM CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, today announces a change of chairmanship on its board of…
Mithra completes the private placement of EUR 23.5 million – 06/24/2022 at 6:00 pm
Liège, Belgium, June 24, 2022 – 6:00 p.m. CET – Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the “Company” or “Mithra”), a company dedicated to women’s health, today announces that it…
Mithra: what valuation?
By Claude Leguilloux Published on 06/21/2022 at 12:19 p.m. Mithras announces that it has received commitments for an amount of 23.5 ME from current…
Mithra announces the resignation of François Fornieri as non-executive director – 06/20/2022 at 07:30
Liège, Belgium, June 20, 2022 – 7:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, announces today that Mr. François Fornieri has tendered his resignation as…
Mithra Pharmaceuticals SA: CDMO announces collaboration with MedinCell for the development of injectables against malaria and transplant rejection
Liège, Belgium, April 26, 2022 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, announces today that it has signed a partnership agreement with MedinCell…